{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T23:31:46Z","timestamp":1787614306251,"version":"build-2736575974"},"reference-count":155,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.bbadis.2021.166148","type":"journal-article","created":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T01:56:40Z","timestamp":1618970200000},"page":"166148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Novel molecular markers of cardiovascular disease risk in type 2 diabetes mellitus"],"prefix":"10.1016","volume":"1867","author":[{"given":"Rosaria Vincenza","family":"Giglio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca Pantea","family":"Stoian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Haluzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalliopi","family":"Pafili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo Maria","family":"Patti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Abbas","family":"Rizvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Ciaccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Papanas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfredi","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.bbadis.2021.166148_bb0005","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.2174\/0929867324666170710121145","article-title":"Metabolic syndrome: sex-related cardiovascular risk and therapeutic approach","volume":"24","author":"Santilli","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bbadis.2021.166148_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2018.06.004","article-title":"Autophagy as an emerging target in cardiorenal metabolic disease: from pathophysiology to management","volume":"191","author":"Zhang","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbadis.2021.166148_bb0015","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1741-7015-9-48","article-title":"Metabolic syndrome: definitions and controversies","volume":"9","author":"Kassi","year":"2011","journal-title":"BMC Med."},{"issue":"11","key":"10.1016\/j.bbadis.2021.166148_bb0020","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2119\/2008-00058.Rabe","article-title":"Adipokines and insulin resistance","volume":"14","author":"Rabe","year":"2008","journal-title":"Mol. Med."},{"issue":"9","key":"10.1016\/j.bbadis.2021.166148_bb0025","doi-asserted-by":"crossref","first-page":"6146","DOI":"10.3390\/ijms12096146","article-title":"Different impacts of cardiovascular risk factors on oxidative stress","volume":"12","author":"Mansego","year":"2011","journal-title":"Int. J. Mol. Sci."},{"issue":"25","key":"10.1016\/j.bbadis.2021.166148_bb0030","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1056\/NEJMoa052187","article-title":"Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications (DCCT\/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes","volume":"353","author":"Nathan","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.bbadis.2021.166148_bb0035","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41572-019-0098-8","article-title":"Gestational diabetes mellitus","volume":"5","author":"McIntyre","year":"2019","journal-title":"Nat. Rev. Dis. Primers."},{"issue":"5","key":"10.1016\/j.bbadis.2021.166148_bb0040","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1530\/EC-18-0130","article-title":"Metabolic disorders during pregnancy and postpartum cardiometabolic risk","volume":"7","author":"Patti","year":"2018","journal-title":"Endocr. Connect."},{"key":"10.1016\/j.bbadis.2021.166148_bb0045","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.yjmcc.2012.08.023","article-title":"Maternal obesity, lipotoxicity and cardiovascular diseases in offspring","volume":"55","author":"Dong","year":"2013","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"1","key":"10.1016\/j.bbadis.2021.166148_bb0050","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2174\/1389201015666140330193653","article-title":"Gestational diabetes and the metabolic syndrome: can obesity and small, dense low density lipoproteins be key mediators of this association?","volume":"15","author":"Rizvi","year":"2014","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"1","key":"10.1016\/j.bbadis.2021.166148_bb0055","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12933-018-0728-6","article-title":"Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007\u20132017","volume":"17","author":"Einarson","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.bbadis.2021.166148_bb0060","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijcard.2016.11.156","article-title":"Cardiorenal acute kidney injury: epidemiology, presentation, causes, pathophysiology and treatment","volume":"227","author":"Lullo","year":"2017","journal-title":"Int. J. Cardiol."},{"issue":"3","key":"10.1016\/j.bbadis.2021.166148_bb0065","first-page":"142","article-title":"Role of chronic kidney disease and associated biochemical alteration on arterial stiffness in T2 diabetic patients without cardiovascular disease","volume":"35","author":"Rotondi","year":"2020","journal-title":"Nephrol. Dial. Transplant."},{"issue":"4","key":"10.1016\/j.bbadis.2021.166148_bb0070","doi-asserted-by":"crossref","first-page":"912","DOI":"10.3390\/jcm9040912","article-title":"Impact of glucose-lowering medications on cardiovascular and metabolic risk in type 2 diabetes","volume":"9","author":"Patti","year":"2020","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.bbadis.2021.166148_bb0075","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.pcd.2013.03.002","article-title":"On the imporberezintance of global cardiovascular risk assessment in people with type 2 diabetes","volume":"7","author":"Echouffo-Tcheugui","year":"2013","journal-title":"Prim Care Diabetes."},{"issue":"1","key":"10.1016\/j.bbadis.2021.166148_bb0080","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1373\/clinchem.2016.255539","article-title":"Use of biomarkers in predicting the onset, monitoring the progression, and risk stratification for patients with type 2 diabetes mellitus","volume":"63","author":"Scirica","year":"2017","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bbadis.2021.166148_bb0085","doi-asserted-by":"crossref","first-page":"8208609","DOI":"10.1155\/2017\/8208609","article-title":"Biomarkers of cardiovascular disease","volume":"2017","author":"Huang","year":"2017","journal-title":"Dis. Markers"},{"issue":"39","key":"10.1016\/j.bbadis.2021.166148_bb0090","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1093\/eurheartj\/eht108","volume":"34","author":"Authors\/Task Force Members","year":"2013","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.bbadis.2021.166148_bb0095","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.003048","article-title":"Novel biomarkers to improve the prediction of cardiovascular event risk in type 2 diabetes mellitus","volume":"5","author":"van der Leeuw","year":"2016","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.bbadis.2021.166148_bb0100","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ahj.2015.12.015","article-title":"High-sensitive troponin T is associated with all-cause and cardiovascular mortality in stable outpatients with type 2 diabetes (ZODIAC-37)","volume":"174","author":"Hendriks","year":"2016","journal-title":"Am. Heart J."},{"key":"10.1016\/j.bbadis.2021.166148_bb0105","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.atherosclerosis.2016.04.015","article-title":"Inflammation biomarkers and mortality prediction in patients with type 2 diabetes (ZODIAC-27)","volume":"250","author":"Landman","year":"2016","journal-title":"Atherosclerosis."},{"issue":"6","key":"10.1016\/j.bbadis.2021.166148_bb0110","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s00125-015-3535-6","article-title":"Protein biomarkers for the prediction of cardiovascular disease in type 2 diabetes","volume":"58","author":"Looker","year":"2015","journal-title":"Diabetologia."},{"issue":"21","key":"10.1016\/j.bbadis.2021.166148_bb0115","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1161\/CIRCULATIONAHA.116.023233","article-title":"Plasma lipidomic profiles improve on traditional risk factors for the prediction of cardiovascular events in type 2 diabetes mellitus","volume":"134","author":"Alshehry","year":"2016","journal-title":"Circulation."},{"issue":"4","key":"10.1016\/j.bbadis.2021.166148_bb0120","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jama.286.4.421","article-title":"Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals","volume":"286","author":"Gerstein","year":"2001","journal-title":"JAMA."},{"issue":"7","key":"10.1016\/j.bbadis.2021.166148_bb0125","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1007\/s00125-004-1451-2","article-title":"Simple non-invasive assessment of advanced glycation endproduct accumulation","volume":"47","author":"Meerwaldt","year":"2004","journal-title":"Diabetologia."},{"issue":"2","key":"10.1016\/j.bbadis.2021.166148_bb0130","doi-asserted-by":"crossref","DOI":"10.11613\/BM.2019.020901","article-title":"Establishing the 99 th percentile for high sensitivity cardiac troponin I in healthy blood donors from Southern Italy","volume":"29","author":"Agnello","year":"2019","journal-title":"Biochem. Med."},{"issue":"8","key":"10.1016\/j.bbadis.2021.166148_bb0135","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.2337\/dc19-0048","article-title":"Utility of plasma concentration of trimethylamine N-oxide in predicting cardiovascular and renal complications in individuals with type 1 diabetes","volume":"42","author":"Winther","year":"2019","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.bbadis.2021.166148_bb0140","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/jcp.2005.027235","article-title":"Colocalisation of intraplaque C reactive protein, complement, oxidised low density lipoprotein, and macrophages in stable and unstable angina and acute myocardial infarction","volume":"59","author":"Meuwissen","year":"2006","journal-title":"J. Clin. Pathol."},{"issue":"2","key":"10.1016\/j.bbadis.2021.166148_bb0145","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.amjcard.2005.11.014","article-title":"Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)\u2014an C-reactive protein be used to target statin therapy in primary prevention?","volume":"97","author":"Mora","year":"2006","journal-title":"Am. J. Cardiol."},{"issue":"6","key":"10.1016\/j.bbadis.2021.166148_bb0150","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0026-0495(98)90031-2","article-title":"Plasma homocysteine concentrations are regulated by acute hyperinsulinemia in nondiabetic but not type 2 diabetic subjects","volume":"47","author":"Fonseca","year":"1998","journal-title":"Metabolism."},{"issue":"6","key":"10.1016\/j.bbadis.2021.166148_bb0155","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.2337\/diacare.22.6.1004b","article-title":"Acute hyperinsulinemia reduces plasma concentrations of homocysteine in healthy men","volume":"22","author":"Nagai","year":"1999","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.bbadis.2021.166148_bb0160","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2147\/TCRM.S1807","article-title":"Therapeutical approach to plasma homocysteine and cardiovascular risk reduction","volume":"4","author":"Ciaccio","year":"2008","journal-title":"Ther. Clin. Risk Manag."},{"issue":"6","key":"10.1016\/j.bbadis.2021.166148_bb0165","first-page":"999","article-title":"Association between homocysteinemia and metabolic syndrome in patients with cardiovascular disease","volume":"3","author":"Bellia","year":"2007","journal-title":"Ther. Clin. Risk Manag."},{"issue":"20","key":"10.1016\/j.bbadis.2021.166148_bb0170","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMra0800239","article-title":"Biomarkers in heart failure","volume":"358","author":"Braunwald","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2021.166148_bb0175","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cca.2019.06.012","article-title":"Head-to-head comparison of plasma cTnI concentration values measured with three high-sensitivity methods in a large Italian population of healthy volunteers and patients admitted to emergency department with acute coronary syndrome: a multi-center study","volume":"496","author":"Clerico","year":"2019","journal-title":"Clin. Chim. Acta"},{"issue":"11","key":"10.1016\/j.bbadis.2021.166148_bb0180","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1161\/CIRCULATIONAHA.106.655076","article-title":"Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure","volume":"116","author":"Latini","year":"2007","journal-title":"Circulation."},{"issue":"4","key":"10.1016\/j.bbadis.2021.166148_bb0185","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1056\/NEJM199007263230405","article-title":"Elevated circulating levels of tumor necrosis factor in severe chronic heart failure","volume":"323","author":"Levine","year":"1990","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.bbadis.2021.166148_bb0190","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.amjcard.2005.03.006","article-title":"Immune activation in chronic heart failure","volume":"95","author":"Torre-Amione","year":"2005","journal-title":"Am. J. Cardiol."},{"issue":"5","key":"10.1016\/j.bbadis.2021.166148_bb0195","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1161\/CIRCRESAHA.107.161687","article-title":"Identification of cardiac-specific myosin light chain kinase","volume":"102","author":"Chan","year":"2008","journal-title":"Circ. Res."},{"issue":"22","key":"10.1016\/j.bbadis.2021.166148_bb0200","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1161\/CIRCULATIONAHA.112.116202","article-title":"Myosin light chain phosphorylation is critical for adaptation to cardiac stress","volume":"126","author":"Warren","year":"2012","journal-title":"Circulation."},{"issue":"10","key":"10.1016\/j.bbadis.2021.166148_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141130","article-title":"New isoform of cardiac myosin light chain kinase and the role of cardiac myosin phosphorylation in \u03b11-adrenoceptor mediated inotropic response","volume":"10","author":"Taniguchi","year":"2015","journal-title":"PLoS One"},{"issue":"27","key":"10.1016\/j.bbadis.2021.166148_bb0210","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.1073\/pnas.1600633113","article-title":"Cardiac myosin light chain is phosphorylated by Ca2+\/calmodulin-dependent and -independent kinase activities","volume":"113","author":"Chang","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"17","key":"10.1016\/j.bbadis.2021.166148_bb0215","doi-asserted-by":"crossref","first-page":"10703","DOI":"10.1074\/jbc.M115.642165","article-title":"Constitutive phosphorylation of cardiac myosin regulatory light chain in vivo","volume":"290","author":"Chang","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"21","key":"10.1016\/j.bbadis.2021.166148_bb0220","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1073\/pnas.1602776113","article-title":"Myosin light chain phosphorylation enhances contraction of heart muscle via structural changes in both thick and thin filaments","volume":"113","author":"Kampourakis","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.bbadis.2021.166148_bb0225","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.diabres.2013.03.023","article-title":"Added value of novel circulating and genetic biomarkers in type 2 diabetes prediction: a systematic review","volume":"101","author":"Echouffo-Tcheugui","year":"2013","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"7","key":"10.1016\/j.bbadis.2021.166148_bb0230","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/gepi.22243","article-title":"Heritability analysis of nontraditional glycemic biomarkers in the Atherosclerosis Risk in Communities Study","volume":"43","author":"Loomis","year":"2019","journal-title":"Genet. Epidemiol."},{"key":"10.1016\/j.bbadis.2021.166148_bb0235","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1093\/eurheartj\/sux027","article-title":"ANMCO\/ELAS\/SIBioC consensus document: biomarkers in heart failure","volume":"19","author":"Aspromonte","year":"2017","journal-title":"Eur. Heart J. Suppl."},{"issue":"1","key":"10.1016\/j.bbadis.2021.166148_bb0240","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.atherosclerosis.2007.03.034","article-title":"Atherogenic lipoprotein phenotype and LDL size and subclasses in patients with peripheral arterial disease","volume":"197","author":"Rizzo","year":"2008","journal-title":"Atherosclerosis."},{"issue":"2","key":"10.1016\/j.bbadis.2021.166148_bb0245","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.atherosclerosis.2009.07.015","article-title":"Atherogenic lipoprotein phenotype and LDL size and subclasses in drug-naive patients with early rheumatoid arthritis","volume":"207","author":"Rizzo","year":"2009","journal-title":"Atherosclerosis."},{"issue":"12","key":"10.1016\/j.bbadis.2021.166148_bb0250","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/j.1464-5491.2008.02613.x","article-title":"Atherogenic lipoprotein phenotype and LDL size and subclasses in women with gestational diabetes","volume":"25","author":"Rizzo","year":"2008","journal-title":"Diabet. Med."},{"issue":"9","key":"10.1016\/j.bbadis.2021.166148_bb0255","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.metabol.2009.12.018","article-title":"Ethnic differences in serum lipoproteins and their determinants in South African women","volume":"59","author":"Goedecke","year":"2010","journal-title":"Metabolism."},{"issue":"3","key":"10.1016\/j.bbadis.2021.166148_bb0260","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10557-006-8283-x","article-title":"The clinical relevance of low-density-lipoproteins size modulation by statins","volume":"20","author":"Rizzo","year":"2006","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"3","key":"10.1016\/j.bbadis.2021.166148_bb0265","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1517\/14656566.9.3.343","article-title":"Comparative effects of rosiglitazone and pioglitazone on fasting and postprandial low-density lipoprotein size and subclasses in patients with Type 2 diabetes","volume":"9","author":"Berneis","year":"2008","journal-title":"Expert. Opin. Pharmacother."},{"issue":"11","key":"10.1016\/j.bbadis.2021.166148_bb0270","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1111\/j.1742-1241.2007.01596.x","article-title":"Who needs to care about small, dense low-density lipoproteins?","volume":"61","author":"Rizzo","year":"2007","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.bbadis.2021.166148_bb0275","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3389\/fphar.2015.00299","article-title":"Bergamot reduces plasma lipids, atherogenic small dense LDL, and subclinical atherosclerosis in subjects with moderate hypercholesterolemia: a 6\u202fmonths prospective study","volume":"6","author":"Toth","year":"2016","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.bbadis.2021.166148_bb0280","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.beem.2013.11.001","article-title":"Emerging therapies for raising high-density lipoprotein cholesterol (HDL-C) and augmenting HDL particle functionality","volume":"28","author":"Barylski","year":"2014","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.bbadis.2021.166148_bb0285","doi-asserted-by":"crossref","first-page":"844","DOI":"10.5114\/aoms.2016.60971","article-title":"Subfractions of high-density lipoprotein (HDL) and dysfunctional HDL in chronic kidney disease patients","volume":"12","author":"Rysz-G\u00f3rzy\u0144ska","year":"2016","journal-title":"Arch. Med. Sci."},{"issue":"29","key":"10.1016\/j.bbadis.2021.166148_bb0290","doi-asserted-by":"crossref","first-page":"17895","DOI":"10.1074\/jbc.272.29.17895","article-title":"Platelet-activating factor acetylhydrolases","volume":"272","author":"Stafforini","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bbadis.2021.166148_bb0295","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1084\/jem.20070029","article-title":"Importance of group X-secreted phospholipase A2 in allergen-induced airway inflammation and remodeling in a mouse asthma model","volume":"204","author":"Henderson","year":"2007","journal-title":"J. Exp. Med."},{"issue":"7","key":"10.1016\/j.bbadis.2021.166148_bb0300","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1161\/01.ATV.0000221231.56617.67","article-title":"Secretory phospholipase A2 group V: lesion distribution, activation by arterial proteoglycans, and induction in aorta by a western diet","volume":"26","author":"Rosengren","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"13","key":"10.1016\/j.bbadis.2021.166148_bb0305","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/eurheartj\/ehs092","volume":"33","author":"Perk","year":"2012","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.bbadis.2021.166148_bb0310","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10557-008-6132-9","article-title":"Phospholipase a2 biochemistry","volume":"23","author":"Burke","year":"2009","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"2","key":"10.1016\/j.bbadis.2021.166148_bb0315","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2147\/vhrm.2006.2.2.153","article-title":"Lipoprotein-associated phospholipase A2, vascular inflammation and cardiovascular risk prediction","volume":"2","author":"Sudhir","year":"2006","journal-title":"Vasc. Health Risk Manag."},{"issue":"3","key":"10.1016\/j.bbadis.2021.166148_bb0320","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1161\/res.90.3.251","article-title":"Matrix metalloproteinases in vascular remodeling and atherogenesis. The good, the bad, and the ugly","volume":"90","author":"Galis","year":"2002","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbadis.2021.166148_bb0325","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.matbio.2015.01.015","article-title":"Metalloproteinases promote plaque rupture and myocardial infarction: a persuasive concept waiting for clinical translation","volume":"44","author":"Newby","year":"2015","journal-title":"Matrix Biol."},{"issue":"11","key":"10.1016\/j.bbadis.2021.166148_bb0330","first-page":"1657","article-title":"Comparision of high sensitivity C-reactive protein and matrix metalloproteinase 9 in patients with unstable angina between with and without significant coronary artery plaques","volume":"124","author":"Wang","year":"2011","journal-title":"Chin. Med. J."},{"issue":"6","key":"10.1016\/j.bbadis.2021.166148_bb0335","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1160\/TH13-07-0588","article-title":"Matrix metalloproteinase-2 of human carotid atherosclerotic plaques promotes platelet activation. Correlation with ischemic events","volume":"111","author":"Lenti","year":"2014","journal-title":"Thromb. Haemost."},{"issue":"18","key":"10.1016\/j.bbadis.2021.166148_bb0340","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1093\/eurheartj\/ehq517","article-title":"Collagenase matrix metalloproteinase-8 expressed in atherosclerotic carotid plaques is associated with systemic cardiovascular outcome","volume":"32","author":"Peeters","year":"2011","journal-title":"Eur. Heart J."},{"issue":"7","key":"10.1016\/j.bbadis.2021.166148_bb0345","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1161\/ATVBAHA.115.305631","article-title":"Elevated plasma levels of MMP-12 are associated with atherosclerotic burden and symptomatic cardiovascular disease in subjects with type 2 diabetes","volume":"35","author":"Goncalves","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"9466","key":"10.1016\/j.bbadis.2021.166148_bb0350","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(05)74811-X","article-title":"Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery","volume":"365","author":"Mishra","year":"2005","journal-title":"Lancet."},{"issue":"3","key":"10.1016\/j.bbadis.2021.166148_bb0355","doi-asserted-by":"crossref","first-page":"586","DOI":"10.4049\/jimmunol.1900677","article-title":"CD4+ T cell-derived NGAL modifies the outcome of ischemic acute kidney injury","volume":"204","author":"Lee","year":"2020","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.bbadis.2021.166148_bb0360","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ccc.2019.08.010","article-title":"The role of biomarkers in acute kidney injury","volume":"36","author":"Srisawat","year":"2020","journal-title":"Crit. Care Clin."},{"issue":"2","key":"10.1016\/j.bbadis.2021.166148_bb0365","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000209379","article-title":"Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients","volume":"32","author":"Bolignano","year":"2009","journal-title":"Kidney Blood Press Res."},{"issue":"2","key":"10.1016\/j.bbadis.2021.166148_bb0370","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1053\/j.ajkd.2014.07.025","article-title":"Urine neutrophil gelatinase-associated lipocalin and risk of cardiovascular disease and death in CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) study","volume":"65","author":"Liu","year":"2015","journal-title":"Am. J. Kidney Dis."},{"issue":"1","key":"10.1016\/j.bbadis.2021.166148_bb0375","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1089\/rej.2008.0803","article-title":"Increased plasma neutrophil gelatinase-associated lipocalin levels predict mortality in elderly patients with chronic heart failure","volume":"12","author":"Bolignano","year":"2009","journal-title":"Rejuvenation Res."},{"issue":"2","key":"10.1016\/j.bbadis.2021.166148_bb0380","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neulet.2005.10.022","article-title":"Benfotiamine alleviates diabetes-induced cerebral oxidative damage independent of advanced glycation end-product, tissue factor and TNF-alpha","volume":"394","author":"Wu","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbadis.2021.166148_bb0385","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.toxlet.2017.11.018","article-title":"Inhibition of advanced glycation endproduct (AGE) rescues against streptozotocin-induced diabetic cardiomyopathy: role of autophagy and ER stress","volume":"284","author":"Pei","year":"2018","journal-title":"Toxicol. Lett."},{"issue":"1","key":"10.1016\/j.bbadis.2021.166148_bb0390","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1515\/cclm-2017-0179","article-title":"Definition of the upper reference limit of glycated albumin in blood donors from Italy","volume":"56","author":"Bellia","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"issue":"16","key":"10.1016\/j.bbadis.2021.166148_bb0395","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003362","article-title":"Glycated albumin is independently associated with arterial stiffness in non-diabetic chronic kidney disease patients","volume":"95","author":"Choi","year":"2016","journal-title":"Medicine."},{"issue":"7","key":"10.1016\/j.bbadis.2021.166148_bb0400","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1253\/circj.71.1067","article-title":"Increased serum glycated albumin level is associated with the presence and severity of coronary artery disease in type 2 diabetic patients","volume":"71","author":"Pu","year":"2007","journal-title":"Circ. J."},{"issue":"2","key":"10.1016\/j.bbadis.2021.166148_bb0405","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.atherosclerosis.2012.09.005","article-title":"Serum glycated albumin predicts the progression of carotid arterial atherosclerosis","volume":"225","author":"Song","year":"2012","journal-title":"Atherosclerosis."},{"issue":"2","key":"10.1016\/j.bbadis.2021.166148_bb0410","doi-asserted-by":"crossref","first-page":"260","DOI":"10.4103\/1319-2442.109568","article-title":"Glycated albumin versus glycated hemoglobin as glycemic indicator in hemodialysis patients with diabetes mellitus: variables that influence","volume":"24","author":"Sany","year":"2013","journal-title":"Saudi J. Kidney Dis. Transpl."},{"issue":"11","key":"10.1016\/j.bbadis.2021.166148_bb0415","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.clinbiochem.2007.03.022","article-title":"Association of serum levels of glycated albumin, C-reactive protein and tumor necrosis factor-alpha with the severity of coronary artery disease and renal impairment in patients with type 2 diabetes mellitus","volume":"40","author":"Lu","year":"2007","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.bbadis.2021.166148_bb0420","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.clinbiochem.2018.02.017","article-title":"Clinical usefulness of glycated albumin in the diagnosis of diabetes: results from an Italian study","volume":"54","author":"Bellia","year":"2018","journal-title":"Clin. Biochem."},{"issue":"7","key":"10.1016\/j.bbadis.2021.166148_bb0425","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/dmrr.1117","article-title":"Glycated albumin, a precursor of advanced glycation end-products, up-regulates NADPH oxidase and enhances oxidative stress in human endothelial cells: molecular correlate of diabetic vasculopathy","volume":"26","author":"Rodi\u00f1o-Janeiro","year":"2010","journal-title":"Diabetes Metab. Res. Rev."},{"issue":"4","key":"10.1016\/j.bbadis.2021.166148_bb0430","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1067\/mlc.2003.27","article-title":"Glycated albumin increases oxidative stress, activates NF-kappa B and extracellular signal-regulated kinase (ERK), and stimulates ERK-dependent transforming growth factor-beta 1 production in macrophage RAW cells","volume":"141","author":"Cohen","year":"2003","journal-title":"J. Lab. Clin. Med."},{"issue":"9","key":"10.1016\/j.bbadis.2021.166148_bb0435","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1253\/circj.CJ-11-1499","article-title":"Decreased endothelial progenitor cells and increased serum glycated albumin are independently correlated with plaque-forming carotid artery atherosclerosis in type 2 diabetes patients without documented ischemic disease","volume":"76","author":"Moon","year":"2012","journal-title":"Circ. J."},{"issue":"3","key":"10.1016\/j.bbadis.2021.166148_bb0440","doi-asserted-by":"crossref","DOI":"10.11613\/BM.2017.030709","article-title":"Establishing the upper reference limit of Galectin-3 in healthy blood donors","volume":"27","author":"Agnello","year":"2017","journal-title":"Biochem. Med."},{"issue":"4","key":"10.1016\/j.bbadis.2021.166148_bb0445","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.cell.2016.10.025","article-title":"Hematopoietic-derived galectin-3 causes cellular and systemic insulin resistance","volume":"167","author":"Li","year":"2016","journal-title":"Cell."},{"issue":"13\u201314","key":"10.1016\/j.bbadis.2021.166148_bb0450","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.clinbiochem.2017.04.018","article-title":"Galectin-3 in acute coronary syndrome","volume":"50","author":"Agnello","year":"2017","journal-title":"Clin. Biochem."},{"issue":"7","key":"10.1016\/j.bbadis.2021.166148_bb0455","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.arcmed.2016.12.009","article-title":"Short-term changes in Gal 3 circulating levels after acute myocardial infarction","volume":"47","author":"Bivona","year":"2016","journal-title":"Arch. Med. Res."},{"issue":"6","key":"10.1016\/j.bbadis.2021.166148_bb0460","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1474-9726.2010.00629.x","article-title":"Macrophage inhibitory cytokine-1 (MIC-1\/GDF15): a new marker of all-cause mortality","volume":"9","author":"Wiklund","year":"2010","journal-title":"Aging Cell"},{"issue":"21","key":"10.1016\/j.bbadis.2021.166148_bb0465","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1161\/CIRCULATIONAHA.114.011204","volume":"130","author":"Wallentin","year":"2014","journal-title":"Circulation."},{"issue":"5","key":"10.1016\/j.bbadis.2021.166148_bb0470","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nm.2354","article-title":"GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice","volume":"17","author":"Kempf","year":"2011","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.bbadis.2021.166148_bb0475","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1373\/clinchem.2015.246876","article-title":"Evaluation of temporal changes in cardiovascular biomarker concentrations improves risk prediction in an elderly population from the community","volume":"62","author":"Eggers","year":"2016","journal-title":"Clin. Chem."},{"issue":"11","key":"10.1016\/j.bbadis.2021.166148_bb0480","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/ejhf.331","article-title":"Growth differentiation factor 15 (GDF-15) in patients admitted for acute heart failure: results from the RELAX-AHF study","volume":"17","author":"Cotter","year":"2015","journal-title":"Eur. J. Heart Fail."},{"issue":"14","key":"10.1016\/j.bbadis.2021.166148_bb0485","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1161\/CIRCULATIONAHA.107.697714","article-title":"Growth differentiation factor 15 for risk stratification and selection of an invasive treatment strategy in non ST-elevation acute coronary syndrome","volume":"116","author":"Wollert","year":"2007","journal-title":"Circulation."},{"issue":"10","key":"10.1016\/j.bbadis.2021.166148_bb0490","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1093\/eurheartj\/ehp098","article-title":"C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study","volume":"30","author":"Voors","year":"2009","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.bbadis.2021.166148_bb0495","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00431-020-03777-3","article-title":"Distribution of plasma copeptin levels and influence of obesity in children and adolescents","volume":"180","author":"Tuli","year":"2021","journal-title":"Eur. J. Pediatr."},{"issue":"1","key":"10.1016\/j.bbadis.2021.166148_bb0500","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s40618-019-01087-6","article-title":"Copeptin in the differential diagnosis of hypotonic polyuria","volume":"43","author":"Christ-Crain","year":"2020","journal-title":"J. Endocrinol. Investig."},{"issue":"2","key":"10.1016\/j.bbadis.2021.166148_bb0505","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/CCM.0b013e3181957532","article-title":"The vasopressin and copeptin response to infection, severe sepsis, and septic shock","volume":"37","author":"Jochberger","year":"2009","journal-title":"Crit. Care Med."},{"issue":"18","key":"10.1016\/j.bbadis.2021.166148_bb0510","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1136\/hrt.2009.170696","article-title":"Evaluation of novel biomarkers for the diagnosis of acute destabilized heart failure in patients with shortness of breath","volume":"95","author":"Dieplinger","year":"2009","journal-title":"Heart."},{"issue":"10","key":"10.1016\/j.bbadis.2021.166148_bb0515","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0024-3205(99)00358-6","article-title":"Adrenomedullin: potential in physiology and pathophysiology","volume":"66","author":"Jougasaki","year":"2000","journal-title":"Life Sci."},{"issue":"10","key":"10.1016\/j.bbadis.2021.166148_bb0520","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1373\/clinchem.2005.051110","article-title":"Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay","volume":"51","author":"Morgenthaler","year":"2005","journal-title":"Clin. Chem."},{"issue":"17","key":"10.1016\/j.bbadis.2021.166148_bb0525","doi-asserted-by":"crossref","first-page":"329","DOI":"10.21037\/atm.2016.08.65","article-title":"New role of biomarkers: mid-regional pro-adrenomedullin, the biomarker of organ failure","volume":"4","author":"Valenzuela-S\u00e1nchez","year":"2016","journal-title":"Ann. Transl. Med."},{"issue":"4","key":"10.1016\/j.bbadis.2021.166148_bb0530","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1515\/cclm-2018-0645","article-title":"Mid-regional pro-adrenomedullin predicts poor outcome in non-selected patients admitted to an intensive care unit","volume":"57","author":"Bellia","year":"2019","journal-title":"Clin. Chem. Lab. Med."},{"issue":"10","key":"10.1016\/j.bbadis.2021.166148_bb0535","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1097\/HJH.0b013e328362fe99","article-title":"Adrenomedullin is a marker of carotid plaques and intima-media thickness as well as brachial pulse pressure","volume":"31","author":"Gotts\u00e4ter","year":"2013","journal-title":"J. Hypertens."},{"issue":"1","key":"10.1016\/j.bbadis.2021.166148_bb0540","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3109\/10409238909082552","article-title":"The family of glycogen phosphorylases: structure and function","volume":"24","author":"Newgard","year":"1989","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"issue":"1","key":"10.1016\/j.bbadis.2021.166148_bb0545","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0009-8981(97)00254-4","article-title":"Glycogen phosphorylase isoenzyme BB to diagnose ischaemic myocardial damage","volume":"272","author":"Mair","year":"1998","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.bbadis.2021.166148_bb0550","doi-asserted-by":"crossref","first-page":"78","DOI":"10.11613\/BM.2013.010","article-title":"Glycogen phosphorylase isoenzyme BB in the diagnosis of acute myocardial infarction: a meta-analysis","volume":"23","author":"Lippi","year":"2013","journal-title":"Biochem. Med."},{"issue":"11","key":"10.1016\/j.bbadis.2021.166148_bb0555","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1111\/acem.12250","article-title":"ST2 in emergency department patients with noncardiac dyspnea","volume":"20","author":"Benoit","year":"2013","journal-title":"Acad. Emerg. Med."},{"issue":"3","key":"10.1016\/j.bbadis.2021.166148_bb0560","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1373\/clinchem.2013.209858","article-title":"Increased soluble ST2 predicts long-term mortality in patients with stable coronary artery disease: results from the Ludwigshafen risk and cardiovascular health study","volume":"60","author":"Dieplinger","year":"2014","journal-title":"Clin. Chem."},{"issue":"5","key":"10.1016\/j.bbadis.2021.166148_bb0565","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1161\/01.CIR.0000047274.66749.FE","article-title":"Identification of serum soluble ST2 receptor as a novel heart failure biomarker","volume":"107","author":"Weinberg","year":"2003","journal-title":"Circulation."},{"issue":"1","key":"10.1016\/j.bbadis.2021.166148_bb0570","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cca.2009.08.010","article-title":"Analytical and clinical evaluation of a novel high-sensitivity assay for measurement of soluble ST2 in human plasma-the presage ST2 assay","volume":"409","author":"Dieplinger","year":"2009","journal-title":"Clin. Chim. Acta"},{"issue":"7","key":"10.1016\/j.bbadis.2021.166148_bb0575","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jacc.2007.05.014","article-title":"Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study","volume":"50","author":"Januzzi","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.bbadis.2021.166148_bb0580","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1536\/ihj.13-371","article-title":"Elevated soluble ST2 and depression increased the risk of all-cause mortality and hospitalization in patients with heart failure","volume":"55","author":"Xu","year":"2014","journal-title":"Int. Heart J."},{"issue":"1\u20132","key":"10.1016\/j.bbadis.2021.166148_bb0585","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cccn.2004.09.001","article-title":"Fatty acid-binding proteins as plasma markers of tissue injury","volume":"352","author":"Pelsers","year":"2005","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bbadis.2021.166148_bb0590","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clinbiochem.2018.04.021","article-title":"Diagnostic and prognostic value of H-FABP in acute coronary syndrome: still evidence to bring","volume":"58","author":"Bivona","year":"2018","journal-title":"Clin. Biochem."},{"issue":"5","key":"10.1016\/j.bbadis.2021.166148_bb0595","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094834","article-title":"Association of heart-type fatty acid-binding protein with cardiovascular risk factors and all-cause mortality in the general population: the Takahata study","volume":"9","author":"Otaki","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bbadis.2021.166148_bb0600","first-page":"7","article-title":"A study on the role of heart type fatty acid binding protein in the diagnosis of acute myocardial infarction","volume":"10","author":"Kabekkodu","year":"2016","journal-title":"J. Clin. Diagn. Res."},{"issue":"17","key":"10.1016\/j.bbadis.2021.166148_bb0605","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1001\/jama.286.17.2136","article-title":"Association between myeloperoxidase levels and risk of coronary artery disease","volume":"286","author":"Zhang","year":"2001","journal-title":"JAMA."},{"issue":"6","key":"10.1016\/j.bbadis.2021.166148_bb0610","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1161\/01.ATV.0000163262.83456.6d","article-title":"Myeloperoxidase and cardiovascular disease","volume":"25","author":"Nicholls","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.bbadis.2021.166148_bb0615","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.atherosclerosis.2013.08.037","article-title":"Gender-specific correlation between plasma myeloperoxidase levels and serum high-density lipoprotein-associated paraoxonase-1 levels in patients with stable and unstable coronary artery disease","volume":"231","author":"Yunoki","year":"2013","journal-title":"Atherosclerosis."},{"issue":"12","key":"10.1016\/j.bbadis.2021.166148_bb0620","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1373\/clinchem.2011.166827","article-title":"Risk prediction with serial myeloperoxidase monitoring in patients with acute chest pain","volume":"57","author":"Nicholls","year":"2011","journal-title":"Clin. Chem."},{"issue":"8","key":"10.1016\/j.bbadis.2021.166148_bb0625","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2020.107613","article-title":"Molecular complexities underlying the vascular complications of diabetes mellitus - a comprehensive review","volume":"34","author":"Paul","year":"2020","journal-title":"J. Diabetes Complicat."},{"issue":"9","key":"10.1016\/j.bbadis.2021.166148_bb0630","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1089\/ars.2020.8107","article-title":"MicroRNAs as master regulators of atherosclerosis: from pathogenesis to novel therapeutic options","volume":"33","author":"Hosen","year":"2020","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bbadis.2021.166148_bb0635","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3389\/fendo.2018.00074","article-title":"The potential role of platelet-related microRNAs in the development of cardiovascular events in high-risk populations, including diabetic patients: a review","volume":"9","author":"Pordzik","year":"2018","journal-title":"Front. Endocrinol."},{"issue":"31","key":"10.1016\/j.bbadis.2021.166148_bb0640","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.2174\/1381612819666131206103102","article-title":"Resistin: an inflammatory cytokine. Role in cardiovascular diseases, diabetes and the metabolic syndrome","volume":"20","author":"Abate","year":"2014","journal-title":"Curr. Pharm. Des."},{"issue":"1","key":"10.1016\/j.bbadis.2021.166148_bb0645","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/met.2013.0090","article-title":"Adipokines and lipoproteins: modulation by antihyperglycemic and hypolipidemic agents","volume":"12","author":"Rizvi","year":"2014","journal-title":"Metab. Syndr. Relat. Disord."},{"issue":"1","key":"10.1016\/j.bbadis.2021.166148_bb0650","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/0003319712468291","article-title":"Predictors of insulin resistance in patients with obesity: a pilot study","volume":"65","author":"Stepien","year":"2014","journal-title":"Angiology."},{"issue":"4","key":"10.1016\/j.bbadis.2021.166148_bb0655","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1177\/0003319713485807","article-title":"New obesity indices and adipokines in normotensive patients and patients with hypertension: comparative pilot analysis","volume":"65","author":"Stepien","year":"2014","journal-title":"Angiology."},{"issue":"31","key":"10.1016\/j.bbadis.2021.166148_bb0660","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.2174\/1381612819666131206102255","article-title":"Incretin-based therapies, glucometabolic health and endovascular inflammation","volume":"20","author":"Rizzo","year":"2014","journal-title":"Curr. Pharm. Des."},{"issue":"8","key":"10.1016\/j.bbadis.2021.166148_bb0665","doi-asserted-by":"crossref","DOI":"10.3390\/cells9081812","article-title":"The inflammasome in chronic complications of diabetes and related metabolic disorders","volume":"9","author":"Menini","year":"2020","journal-title":"Cells."},{"key":"10.1016\/j.bbadis.2021.166148_bb0670","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.freeradbiomed.2019.04.025","article-title":"Hydrogen sulfide protects against DSS-induced colitis by inhibiting NLRP3 inflammasome","volume":"137","author":"Qin","year":"2019","journal-title":"Free Radic. Biol. Med."},{"issue":"2","key":"10.1016\/j.bbadis.2021.166148_bb0675","doi-asserted-by":"crossref","first-page":"94","DOI":"10.7555\/JBR.33.20190071","article-title":"H2S protects against diabetes-accelerated atherosclerosis by preventing the activation of NLRP3 inflammasome","volume":"34","author":"Zheng","year":"2019","journal-title":"J. Biomed. Res."},{"issue":"6","key":"10.1016\/j.bbadis.2021.166148_bb0680","first-page":"612","article-title":"Multisociety consensus quality improvement revised consensus statement for endovascular therapy of acute ischemic stroke","volume":"13","author":"Sacks","year":"2018","journal-title":"Int. J. Stroke"},{"issue":"5","key":"10.1016\/j.bbadis.2021.166148_bb0685","first-page":"292","article-title":"Coronary, peripheral and cerebrovascular disease: a complex relationship","volume":"108","author":"Shah","year":"2010","journal-title":"J. Indian Med. Assoc."},{"issue":"2","key":"10.1016\/j.bbadis.2021.166148_bb0690","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1161\/01.STR.0000198813.56398.14","article-title":"Markers of inflammation and infection influence the outcome of patients with baseline asymptomatic carotid lesions: a 5-year follow-up study","volume":"37","author":"Corrado","year":"2006","journal-title":"Stroke."},{"issue":"2","key":"10.1016\/j.bbadis.2021.166148_bb0695","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0735-1097(01)01746-6","article-title":"Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force","volume":"39","author":"Corretti","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.bbadis.2021.166148_bb0700","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/MCA.0b013e3282f3fbde","article-title":"Endothelial dysfunction and carotid lesions are strong predictors of clinical events in patients with early stages of atherosclerosis: a 24-month follow-up study","volume":"19","author":"Corrado","year":"2008","journal-title":"Coron. Artery Dis."},{"issue":"5","key":"10.1016\/j.bbadis.2021.166148_bb0705","first-page":"1","article-title":"Diagnosis of vascular diseases ultrasound investigations - guidelines","volume":"31","author":"Antignani","year":"2012","journal-title":"Int. Angiol."},{"issue":"3","key":"10.1016\/j.bbadis.2021.166148_bb0710","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1161\/01.STR.26.3.386","article-title":"Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) Study","volume":"26","author":"Burke","year":"1995","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.bbadis.2021.166148_bb0715","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.echo.2007.11.011","volume":"21","author":"Stein","year":"2008","journal-title":"J. Am. Soc. Echocardiogr."},{"issue":"6","key":"10.1016\/j.bbadis.2021.166148_bb0720","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/RCT.0000000000000825","article-title":"Coronary artery calcium scoring: current status and review of literature","volume":"42","author":"Malguria","year":"2018","journal-title":"J. Comput. Assist. Tomogr."},{"issue":"15","key":"10.1016\/j.bbadis.2021.166148_bb0725","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1093\/eurheartj\/ehr157","article-title":"Inter-scan variability of coronary artery calcium scoring assessed on 64-multidetector computed tomography vs. dual-source computed tomography: a head-to-head comparison","volume":"32","author":"Ghadri","year":"2011","journal-title":"Eur. Heart J."},{"issue":"15","key":"10.1016\/j.bbadis.2021.166148_bb0730","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1161\/hc4201.097189","article-title":"Improving coronary heart disease risk assessment in asymptomatic people: role of traditional risk factors and noninvasive cardiovascular tests","volume":"104","author":"Greenland","year":"2001","journal-title":"Circulation."},{"issue":"2","key":"10.1016\/j.bbadis.2021.166148_bb0735","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/jama.300.2.197","article-title":"Ankle brachial index combined with Framingham risk score to predict cardiovascular events and mortality: a meta-analysis","volume":"300","author":"Fowkes","year":"2008","journal-title":"JAMA."},{"issue":"18","key":"10.1016\/j.bbadis.2021.166148_bb0740","doi-asserted-by":"crossref","first-page":"423","DOI":"10.4239\/wjd.v7.i18.423","article-title":"Update on pre-diabetes: focus on diagnostic criteria and cardiovascular risk","volume":"7","author":"Pino","year":"2016","journal-title":"World J. Diabetes"},{"issue":"5","key":"10.1016\/j.bbadis.2021.166148_bb0745","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.2337\/dc13-2357","article-title":"Cardiovascular risk profile in subjects with pre-diabetes and new-onset type 2 diabetes identified by HbA(1c) according to American Diabetes Association criteria","volume":"37","author":"Pino","year":"2014","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.bbadis.2021.166148_bb0750","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.jacc.2017.06.030","article-title":"Biomarker-based risk model to predict cardiovascular mortality in patients with stable coronary disease","volume":"70","author":"Lindholm","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbadis.2021.166148_bb0755","doi-asserted-by":"crossref","first-page":"231","DOI":"10.14503\/THIJ-18-6674","article-title":"Genetic testing in cardiovascular medicine","volume":"45","author":"Marian","year":"2018","journal-title":"Tex. Heart Inst. J."},{"issue":"2","key":"10.1016\/j.bbadis.2021.166148_bb0760","doi-asserted-by":"crossref","first-page":"422","DOI":"10.5114\/aoms.2017.68717","article-title":"Natural approaches in metabolic syndrome management","volume":"14","author":"Patti","year":"2018","journal-title":"Arch. Med. Sci."},{"issue":"5","key":"10.1016\/j.bbadis.2021.166148_bb0765","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/jhn.12748","article-title":"Dietary vitamin D intake, cardiovascular disease and cardiometabolic risk factors: a sex-based analysis from the ATTICA cohort study","volume":"33","author":"Kouvari","year":"2020","journal-title":"J. Hum. Nutr. Diet."},{"issue":"4","key":"10.1016\/j.bbadis.2021.166148_bb0770","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.cegh.2020.05.015","article-title":"Vitamin D gene polymorphisms and risk of acute cardiovascular events","volume":"8","author":"Fox","year":"2020","journal-title":"Clin. Epidemiol. Glob. Health."},{"issue":"1","key":"10.1016\/j.bbadis.2021.166148_bb0775","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3390\/nu12010099","article-title":"Potential beneficial effects of vitamin D in coronary artery disease","volume":"12","author":"Legarth","year":"2019","journal-title":"Nutrients."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443921000818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443921000818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T05:04:16Z","timestamp":1760418256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443921000818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":155,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0925443921000818"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2021.166148","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel molecular markers of cardiovascular disease risk in type 2 diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2021.166148","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"166148"}}